125 related articles for article (PubMed ID: 17524953)
1. De novo Crohn's disease in a renal transplant recipient.
Halim MA; Said T; Nair P; Schmidt I; Hassan A; Johny KV; Al-Muzairai I; Samhan M; Nampoory MR; Al-Mousawi M
Transplant Proc; 2007 May; 39(4):1278-9. PubMed ID: 17524953
[TBL] [Abstract][Full Text] [Related]
2. De-novo [corrected] post renal transplantation inflammatory bowel disease.
Halim MA; Al-Otaibi T; Elsisi A; El-Sayed A; Nair P; Said T; Balaha MA; Nampoory MR
Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):624-6. PubMed ID: 18580024
[TBL] [Abstract][Full Text] [Related]
3. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Gruessner RW
Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
[TBL] [Abstract][Full Text] [Related]
4. Influence of tacrolimus plus mycophenolate mofetil regimens on acute rejection rate and diabetes mellitus development in renal transplant recipients.
Demirbaş A; Tuncer M; Yavuz A; Gürkan A; Kaçar S; Cetinkaya R; Tekin S; Akbaş SH; Akaydin M; Ersoy F; Yakupoğlu G
Transplant Proc; 2004; 36(1):175-7. PubMed ID: 15013338
[TBL] [Abstract][Full Text] [Related]
5. De novo inflammatory bowel disease after pediatric orthotopic liver transplant: a case report.
Dehghani SM; Eshraghian A; Bahador A; Kakaei F; Geramizadeh B; Malek-Hosseini SA
Exp Clin Transplant; 2009 Sep; 7(3):145-8. PubMed ID: 19715523
[TBL] [Abstract][Full Text] [Related]
6. Erosive enterocolitis in mycophenolate mofetil-treated renal-transplant recipients with persistent afebrile diarrhea.
Maes BD; Dalle I; Geboes K; Oellerich M; Armstrong VW; Evenepoel P; Geypens B; Kuypers D; Shipkova M; Geboes K; Vanrenterghem YF
Transplantation; 2003 Mar; 75(5):665-72. PubMed ID: 12640307
[TBL] [Abstract][Full Text] [Related]
7. Conversion from cyclosporine-based immunosuppression to tacrolimus/mycophenolate mofetil in patients with refractory and ongoing acute renal allograft rejection.
Boratyńska M; Banasik M; Patrzałek D; Klinger M
Ann Transplant; 2006; 11(2):51-6. PubMed ID: 17494290
[TBL] [Abstract][Full Text] [Related]
8. Calcineurin inhibitor avoidance with daclizumab, mycophenolate mofetil, and prednisolone in DR-matched de novo kidney transplant recipients.
Asberg A; Midtvedt K; Line PD; Narverud J; Holdaas H; Jenssen T; Reisaeter AV; Johnsen LF; Fauchald P; Hartmann A
Transplantation; 2006 Jul; 82(1):62-8. PubMed ID: 16861943
[TBL] [Abstract][Full Text] [Related]
9. The transmission of donor-derived malignant melanoma to a renal allograft recipient.
Milton CA; Barbara J; Cooper J; Rao M; Russell C; Russ G
Clin Transplant; 2006; 20(5):547-50. PubMed ID: 16968479
[TBL] [Abstract][Full Text] [Related]
10. [De novo hemolytic uremic syndrome in a kidney-pancreas recipient in the postoperative period].
Gutiérrez de la Fuente C; Sola E; Alférez MJ; Navarro A; Cabello M; Burgos D; González Molina M
Nefrologia; 2004; 24 Suppl 3():3-6. PubMed ID: 15219059
[TBL] [Abstract][Full Text] [Related]
11. Histologic features of mycophenolate mofetil-related colitis: a graft-versus-host disease-like pattern.
Papadimitriou JC; Cangro CB; Lustberg A; Khaled A; Nogueira J; Wiland A; Ramos E; Klassen DK; Drachenberg CB
Int J Surg Pathol; 2003 Oct; 11(4):295-302. PubMed ID: 14615824
[TBL] [Abstract][Full Text] [Related]
12. Triple immunosuppression with tacrolimus in pediatric renal transplantation: single-center experience.
Duzova A; Aki T; Bakkaloglu A; Besbas N; Topaloglu R; Ozen S; Ozaltin F; Bilginer Y; Demirkaya E; Bakkaloglu M
Transplant Proc; 2008; 40(1):132-4. PubMed ID: 18261567
[TBL] [Abstract][Full Text] [Related]
13. Crohn's-like changes in the colon due to mycophenolate?
Dalle IJ; Maes BD; Geboes KP; Lemahieu W; Geboes K
Colorectal Dis; 2005 Jan; 7(1):27-34. PubMed ID: 15606581
[TBL] [Abstract][Full Text] [Related]
14. Late developing C4d-positive humoral renal allograft rejection associated with withdrawal of mycophenolate mofetil.
Sun Q; Tang Z; Chen J; Chen H; Liu Z; Li L
Transplant Proc; 2005 Dec; 37(10):4244-5. PubMed ID: 16387089
[TBL] [Abstract][Full Text] [Related]
15. One-year results of basiliximab induction and tacrolimus associated with sequential steroid and MMF treatment in pediatric kidney transplant recipient.
Montini G; Murer L; Ghio L; Pietrobon B; Ginevri F; Ferraresso M; Cardillo M; Scalamogna M; Perfumo F; Edefonti A; Zanon GF; Zacchello G
Transpl Int; 2005 Jan; 18(1):36-42. PubMed ID: 15612981
[TBL] [Abstract][Full Text] [Related]
16. Does mycophenolate mofetil increase the incidence of infections in stable renal transplant recipients initially treated with a two-drug regimen?
Chen Y; Chu SH; Wei TY; Yen TH; Chiang YJ; Wu CT; Chen HW
Transplant Proc; 2004 Sep; 36(7):2122-3. PubMed ID: 15518769
[TBL] [Abstract][Full Text] [Related]
17. De novo immunosuppression with sirolimus and tacrolimus in heart transplant recipients compared with cyclosporine and mycophenolate mofetil: a one-year follow-up analysis.
Zucker MJ; Baran DA; Arroyo LH; Goldstein DJ; Neacy C; Mele L; Weinberg AD; Prendergast TW; Ribner HS
Transplant Proc; 2005 Jun; 37(5):2231-9. PubMed ID: 15964386
[TBL] [Abstract][Full Text] [Related]
18. The use of tacrolimus as induction and maintenance immunosuppression in renal cadaveric transplant recipients over the age of 60.
Xenos EX; Ciancio G; Burke GW; Roth D; Miller J
Clin Transplant; 1997 Oct; 11(5 Pt 2):497-9. PubMed ID: 9361949
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil-induced colitis in children.
Phatak UP; Seo-Mayer P; Jain D; Selbst M; Husain S; Pashankar DS
J Clin Gastroenterol; 2009; 43(10):967-9. PubMed ID: 19609219
[TBL] [Abstract][Full Text] [Related]
20. Three-year observational follow-up of a multicenter, randomized trial on tacrolimus-based therapy with withdrawal of steroids or mycophenolate mofetil after renal transplant.
Pascual J; van Hooff JP; Salmela K; Lang P; Rigotti P; Budde K
Transplantation; 2006 Jul; 82(1):55-61. PubMed ID: 16861942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
